Nasdaq deficiency for share issuance in Medigap acquisition; appoints Joel Markovits as CAO

Reliance Global Group, Inc.

Nasdaq notified Reliance on Jan 31, 2022 of violation of Listing Rule 5635(a) due to share issuances in Medigap acquisition and private placement without shareholder approval.
Company has 45 days to submit a plan of compliance; management is confident it will meet Nasdaq's requirements.
Appointed Joel Markovits as Chief Accounting Officer effective Feb 1, 2022; annual salary $200,000 and grant of 25,000 restricted shares.
Markovits joined Reliance in June 2021; previously audit senior manager at KPMG, CPA.

item 3.01 item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Joel Markovits

Chief Accounting Officer

EZRA · Reliance Global Group, Inc.

Effective: 2022-02-01
Filed: February 4, 2022, 6:59 PM ET

On February 1, 2022, the Company’s Board appointed Joel Markovits as its Chief Accounting Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Joel Markovits was appointed as Chief Accounting Officer at Reliance Global Group, Inc..

Action: appointed
Role: Chief Accounting Officer

Exact text from the filing

On February 1, 2022, the Company’s Board appointed Joel Markovits as its Chief Accounting Officer.

View on SEC.gov

Reliance Global Group, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-003229

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.